Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,091 | 165,922 | 216,890 | 243,574 | 269,907 |
| Receivables | 31,138 | 33,415 | 25,498 | 22,537 | 27,882 |
| Inventories | 41,230 | 40,462 | 40,495 | 45,326 | 46,667 |
| TOTAL | $155,655 | $251,736 | $296,251 | $325,867 | $359,761 |
| Non-Current Assets | |||||
| PPE Net | 142,414 | 146,930 | 151,479 | 158,624 | 162,727 |
| Intangibles | 267,804 | 274,316 | 280,972 | 315,305 | 322,495 |
| Other Non-Current Assets | 37,873 | 40,235 | 41,875 | 49,395 | 51,983 |
| TOTAL | $448,091 | $461,481 | $474,326 | $523,324 | $537,205 |
| Total Assets | $603,746 | $713,217 | $770,577 | $849,191 | $896,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,125 | 5,440 | 5,440 | 5,440 | 5,440 |
| Accounts payable and accrued liabilities | 7,125 | 8,535 | 2,910 | 7,998 | 11,525 |
| Accrued Expenses | 30,169 | 28,647 | 36,567 | 48,136 | 50,202 |
| TOTAL | $38,419 | $42,622 | $44,917 | $61,574 | $69,682 |
| Non-Current Liabilities | |||||
| Long Term Debt | 145,980 | 235,571 | 286,331 | 287,381 | 288,436 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,639 |
| Other Non-Current Liabilities | 43,383 | 38,716 | 63,811 | 57,471 | 68,432 |
| TOTAL | $209,739 | $301,512 | $352,949 | $355,758 | $359,301 |
| Total Liabilities | $248,158 | $344,134 | $397,866 | $417,332 | $428,983 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 259,674 | 258,190 | 257,067 | 255,707 | 255,362 |
| Common Shares | 2,596 | 2,582 | 2,560 | 2,554 | 2,553 |
| Retained earnings | -6,031 | 6,385 | 10,118 | 45,799 | 71,355 |
| Other shareholders' equity | 151,425 | 157,985 | 160,856 | 186,995 | 202,698 |
| TOTAL | $355,588 | $369,083 | $372,711 | $431,859 | $467,983 |
| Total Liabilities And Equity | $603,746 | $713,217 | $770,577 | $849,191 | $896,966 |